18 patients had cardiovascular disease (CVD): nine in the n-3 fatty acid group and nine in the gemfibrozil group. Among the other patients, three had diabetes mellitus (one in the n-3 fatty acid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback